Japan Tobacco Inc. · TSE:2914
Japan Tobacco — FY2022 Earnings Presentation
15 slides from Japan Tobacco's earnings presentation, Feb 14, 2023
Slide 1: JT Group 2022 Results & 2023 Forecasts
JT Group 2022 Results & 2023 Forecasts Nobuya Kato JT Group Chief Financial Officer *Please be reminded that the figures shown on these slides may differ from those shown in the financial statements as they are intended to facilitate the reader’s understanding of individual businesses. *For details
Slide 2: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements. These statements appear in a number of places in this document and include statements regarding the intent, belief, or current and future expectations of our management with respect to our business, financial condition
Slide 3: 2022 Full-year Results
2022 Full-year Results
Slide 4: 2022 Consolidated Results: Record highs across all indicators
2022 Consolidated Results: Achieved record highs across all indicators from revenue to profit* Core revenue at constant FX: +4.8% vs. 2021 (JPY BN) FY2022 vs. 2021 Adjusted operating profit (AOP) at constant FX: +9.0% vs. 2021 • Driven by pricing contributions in the tobacco business Reported Revenu
Slide 5: Tobacco Business: Volume Performance and Financial Results
Tobacco Business: Volume Performance and Financial Results Volume Core revenue and AOP (BnU) FY2022 vs. 2021 • Core revenue increased due to strong pricing benefits Total volume 527.3 -0.5% • AOP increased driven by pricing benefits, partially offset by higher input costs within the supply chain ass
Slide 6: Pharmaceutical and Processed Food Businesses: Financial Results
Pharmaceutical and Processed Food Businesses: Financial Results Pharmaceutical Business • Revenue increased year-on-year driven by sales growth at our consolidated subsidiary, Torii Pharmaceutical, from CORECTIM® Ointment in the area of skin diseases, CEDARCURE® Japanese Cedar (JPY BN) FY2022 vs. 20
Slide 7: 2023 Forecasts
2023 Forecasts
Slide 8: Update on the Russian Market
Update on the Russian Market Business overview of Russian market • While we continue to manufacture and distribute our products, the operating environment remains very challenging • Under these circumstances, the JT Group continues to take necessary decisions to address the changing situation in acc
Slide 9: 2023 Consolidated Financial Forecasts
2023 Consolidated Financial Forecasts Core revenue at constant FX: +2.0% vs. 2022 AOP at constant FX: +0.0% vs. 2022 • Pricing benefits in the tobacco business offset by higher input costs within the supply chain and accelerated investments in HTS* vs. 2022 vs. 2022 (JPY BN) FY2023 *heated tobacco s
Slide 10: Tobacco Business: Volume Outlook and Financial Forecasts
Tobacco Business: Volume Outlook and Financial Forecasts Volume Volume assumption (+) Continues solid share momentum, combustibles volume growth in emerging markets and GTR, as well as RRP volume growth FY2023 (-) Industry volume contraction in Japan, the Philippines, Russia and the UK A decrease of
Slide 11: Pharmaceutical and Processed Food Businesses: Financial Forecasts
Pharmaceutical and Processed Food Businesses : Financial Forecasts Pharmaceutical Business • Revenue: Increase driven by the one-time income from the licensing of patented JT compounds and revenue growth at Torii Pharmaceutical, more than （JPY BN） FY2023 vs. 2022 offsetting lower overseas royalty in
Slide 12: Closing Remarks
Closing Remarks
Slide 13: Closing Remarks
Closing Remarks 2022 Results • Delivered strong profit growth supported by pricing benefits and combustibles share gains overcoming the challenging operating environment • Achieved record highs across all indicators from revenue to profit* supported by Shareholders business momentum and favorable FX
Slide 14: Definitions
<Definitions> Adjusted operating profit (AOP): Operating profit + amortization cost of acquired intangibles arising from business acquisitions + adjusted items (income and costs)* * Adjusted items (income and costs) = impairment losses on goodwill ± restructuring income and costs ± others ~at consta
Slide 15: Definitions
<Definitions> Total volume: The volume of tobacco-based products which excludes contract-manufactured products, waterpipe, RRP devices and related accessories. Combustibles volume: The shipment volume of combustibles which excludes contract-manufactured products, snus, waterpipe, heated tobacco prod